chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 5 vaccines Moderna 2/16/21 Lot# 004M20A;  Moderna 3/16/21 Lot# 031L20A;  Moderna 12/10/21 Lot# 045J21A;  Moderna 5/11/2 Lot# 057M21A;  Pfizer 11/10/22 Lot#GJ6738
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Organ failure, Pyrexia, SARS-CoV-2 test positive, Sepsis
Clinical narrative: In ED, patient was febrile of 104, tested positive for COVID-19.  Patient was not hypoxemic, not hypotensive, normal lactate level Patient However met criteria for severe sepsis with acute organ dysfunction Patient was started on remdesivir, levofloxacin for broader empiric coverage.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 1 dose Janssen
Age: 18.0
Sex: F
Vaccine: TD
Symptoms: Dizziness, Loss of consciousness
Clinical narrative: Patient became lightheaded and briefly passed out directly after vaccine administration. She came too rather quickly, rested in the office, and felt well afterwards.
Age: 57.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Incorrect product formulation administered
Clinical narrative: Moderna Monovalent Adult Booster given instead of Moderna Adult BiValent Booster
Age: 22.0
Sex: F
Vaccine: COVID19-2
Symptoms: Infection
Clinical narrative: Patient seen for initial allergist appointment 2/16/23 per the request of the COVID Medical Exemption committee at patient's employer. While there, Dr. "elected to proceed with vaccination using antihistamine pretreatment with the Pfizer bivalent booster vaccine given recent immunity developed from multiple infections."   Dr. states that, "in his expert opinion, patient should be considered up-to-date on her COVID-19 vaccination as of 2/16/23" although patient did not receive any primary doses. Employer requires that employees complete primary series of vaccines or apply and be approved for a religious or medical exemption. Currently, the Medical Committee is discussing whether patient would be required to obtain 2nd dose of vaccine (per CDC guidelines/employer policy) OR if Dr.'s physician statement of patient's "fully vaccinated status" will suffice.
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 5 vaccines Pfizer 2/12/21 Lot# El9267;  Pfizer 3/5/21 Lot# EN6206;  Moderna 10/29/21 Lot# 052#;  Moderna 4/13/22 Lot# 001M21A; Pfizer 9/12/22 Lot# GH9694
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccine Pfizer 10/11/21 Lot# FF2598;  Pfizer 5/3/22 Lot# FJ4989;
Age: 41.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Incorrect product formulation administered
Clinical narrative: Moderna Monovalent Adult Booster given instead of Moderna Adult BiValent Booster
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after three vaccines pfizer 3/11/21  Lot# EN6201;  Pfizer 4/1/21 Lot# Ew0150;  Pfizer 12/10/21 Lot# FD0809
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Three months later I contracted COVID - 19. I took an at home test and it was positive, afterwards I reach out for a telehealth visit to get a prescription of Paxlovid, but I had to go into office but couldn't make it.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 4/21/21 Lot# 045B21A;  Moderna 5/19/21 Lot# 033B21A;  Moderna 1/13/22 Lot# 041J21A
Age: 50.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Incorrect product formulation administered
Clinical narrative: Moderna Monovalent Adult Booster given instead of Moderna Adult BiValent Booster
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Hospitalization related to COVID 19 following completion of primary vaccine series.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: The patient tested positively for COVID-19 today. She denied SOB, cough, fever, or upper respiratory symptoms.
Age: 89.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: breakthrough case admission after 5 vaccines Moderna 1/12/21 Lot# 012L20A;  Moderna 2/9/21 Lot# 012L20A;  Moderna 10/15/21 Lot# 017F21A;  Moderna 4/6/22 Lot# 048L21A;  Moderna 10/13/22 Lot# 030G22B
Age: 87.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: hospitalization
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 4/2/21 Lot# Ew0150;  Pfizer 4/24/21 Lot3 Ew0150;  Moderna 12/20/21 Lot# 067H21A
Age: 32.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Incorrect product formulation administered
Clinical narrative: Moderna Monovalent Adult Booster given instead of Moderna Adult BiValent Booster
Age: 33.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Incorrect product formulation administered
Clinical narrative: Moderna Monovalent Adult Booster given instead of Moderna Adult BiValent Booster
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Angioedema, Burning sensation, Dyspnoea, Erythema, Pain of skin
Clinical narrative: Angioedema to lips, tongue, torso, and upper extremities. Rish/hives to upper body. Burning sensation  and redness throughout body unable to wear clothes due to painful to tough on skin, appeared as a severe sunburn. Shortness of breath.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Urticaria
Clinical narrative: Angioedema to lips, tongue, torso, and upper extremities. Rish/hives to upper body. Burning sensation  and redness throughout body unable to wear clothes due to painful to tough on skin, appeared as a severe sunburn. Shortness of breath.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: hospitalization
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines  Pfizer 3/23/21 Lot# EP6955;  Pfizer 4/14/21 Lot# Ew0164;  Pfizer 4/11/22  Lot# FK9893
Age: 56.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Incorrect product formulation administered
Clinical narrative: Moderna Monovalent Adult Booster given instead of Moderna Adult BiValent Booster
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with booster
Age: 65.0
Sex: F
Vaccine: PNC20
Symptoms: Erythema, Injection site pain, Nodule, Pain
Clinical narrative: large knot in arm and large red circle for 5 days after; 7 months later pain in muscle where shot was given daily, very sore to touch and to move arm.
Age: 62.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Anticoagulant therapy, Contusion, Deep vein thrombosis, Gait disturbance, Lymphadenopathy
Clinical narrative: I thought I had a cramp in the right calf on 2/27/2023. By that night, it became more and more painful. I tried walking it off and drinking pickle juice, but nothing worked. On Thursday, I could hardly walk. At about 1:00PM on 3/3/2023, I noticed that I had a large bruise on the back of my leg, just below the knee on the calf. By about 6:00 PM, the bruised extended from the bottom of the thigh to just above the crook of the knee; it had gotten larger. At about 7:30PM ET, I went to the ER. I underwent an ultrasound, which indicated that I had a deep vein thrombosis within the right distal superficial femoral vein and the popliteal vein. An eight-millimeter swollen inguinal lymph node was also indicated in the right leg. I was given a LOVENOX injection. They also prescribed me 15 mg of XARELTO, which I am to take twice a day for 21 days. After that, the dosage will be 20 mg twice a day for 30 days. At the time of this writing, it's still very painful. It's not as bad as it was before, but at this point, the pain is about a 7 on a scale from 1 to 10.
Age: 62.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Muscle spasms, Pain in extremity, Ultrasound Doppler abnormal
Clinical narrative: I thought I had a cramp in the right calf on 2/27/2023. By that night, it became more and more painful. I tried walking it off and drinking pickle juice, but nothing worked. On Thursday, I could hardly walk. At about 1:00PM on 3/3/2023, I noticed that I had a large bruise on the back of my leg, just below the knee on the calf. By about 6:00 PM, the bruised extended from the bottom of the thigh to just above the crook of the knee; it had gotten larger. At about 7:30PM ET, I went to the ER. I underwent an ultrasound, which indicated that I had a deep vein thrombosis within the right distal superficial femoral vein and the popliteal vein. An eight-millimeter swollen inguinal lymph node was also indicated in the right leg. I was given a LOVENOX injection. They also prescribed me 15 mg of XARELTO, which I am to take twice a day for 21 days. After that, the dosage will be 20 mg twice a day for 30 days. At the time of this writing, it's still very painful. It's not as bad as it was before, but at this point, the pain is about a 7 on a scale from 1 to 10.
Age: 4.0
Sex: M
Vaccine: MMRV
Symptoms: Crying, Erythema, Injection site erythema, Injection site mass, Injection site swelling
Clinical narrative: Shortly after MMRV was given in Rt thigh, child started complaining ti was hurting and crying and refused to allow any touching or going near to the area. By the evening  area was red. By next day (3/21), injection site redness and swelling was increasing and child refused to allow any one near site. By 5pm 3/21 evening, the site was very red, warm to touch and had lump the size of redness. Site measuring  6.35 cms. By 3/22 7am, affected site had enlarged to  7cms. Child continued to complain of pain and tenderness to touch. Assessment on 3/22 by MD, found also Rt middle ear redness and inflammation. Ear resolved over several days  without antibiotic use, as Rt thigh site resolved.
Age: 4.0
Sex: M
Vaccine: MMRV
Symptoms: Injection site warmth, Middle ear inflammation, Pain, Tenderness
Clinical narrative: Shortly after MMRV was given in Rt thigh, child started complaining ti was hurting and crying and refused to allow any touching or going near to the area. By the evening  area was red. By next day (3/21), injection site redness and swelling was increasing and child refused to allow any one near site. By 5pm 3/21 evening, the site was very red, warm to touch and had lump the size of redness. Site measuring  6.35 cms. By 3/22 7am, affected site had enlarged to  7cms. Child continued to complain of pain and tenderness to touch. Assessment on 3/22 by MD, found also Rt middle ear redness and inflammation. Ear resolved over several days  without antibiotic use, as Rt thigh site resolved.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: hospitalization
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Moderna Monovalent Adult Booster given instead of Moderna Adult BiValent Booster
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 2/4/22 LOt# FJ6369;  Pfizer 2/25/22 Lot# FJ6369
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with booster
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines  Moderna 1/4/21 Lot# 039K20A;  Modern 2/1/21 Lot# 012L20A;  MOderna 11/10/21 Lot# 013F21A;  Moderna 4/27/22 Lot# 056A22A
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Nausea, Swelling of eyelid
Clinical narrative: Right eyelid swelling. Painless.   Nausea
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Moderna Monovalent Adult Booster given instead of Moderna Adult BiValent Booster
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular, Vaccine positive rechallenge
Clinical narrative: Irregular periods
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 2/13/21 Lot# El9267;  Pfizer 3/6/21 Lot# EN6206;  Pfizer 11/18/21 Lot# FH8027;
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Moderna Monovalent Adult Booster given instead of Moderna Adult BiValent Booster
Age: 46.0
Sex: M
Vaccine: COVID19-2
Symptoms: Retinopexy, Vitreous detachment
Clinical narrative: S/p pneumatic retinopexy right eye C3F8 (2/14/23) OD CSR
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines  Moderna 3/20/21 Lot# 047A21A;  Moderna 4/17/21 Lot# 040B21A
Age: 0.67
Sex: F
Vaccine: DTAPHEPBIP, PNC13
Symptoms: Pyrexia
Clinical narrative: Fever to 103.9
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines ; Pfizer 1/13/21 Lot# El3249;  Pfizer 2/9/21 Lot# EM9810;  Pfizer 10/13/21 Lot# EW0186
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: Patient was accidentally administered a second bivalent COVID-19 vaccine. System did not flag that the patient already had the updated booster shot in September. Patient did not report any side effects.
Age: 4.0
Sex: M
Vaccine: COVID19-2, DTAPIPV, MMR, VARCEL
Symptoms: No adverse event
Clinical narrative: Accidentally gave bivalent Pfizer Bivalent Booster when the patient had previous completed the primary series with Moderna.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after three vaccines Pfizer 1/18/21 Lot# EK4176;  Pfizer 2/8/21 Lot# EL9264;  Pfizer 12/17/21 Lot# FD7218
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Death, Dyspnoea, Fatigue
Clinical narrative: On 12/5/2022, patient presented to the emergency department from home with complaint of weakness and fatigue. He was hypoxic and required oxygen; his COVID-19 NAA test was positive. Patient was admitted to the hospital for further treatment. He was in stable condition until 12/7/2022 when his respiratory status began declining. His condition continued to decline and required more oxygen and then BiPAP. Patient became dyspneic and hypotensive and was transferred to the ICU. A family meeting was held as patient's respiratory and circulatory status was deteriorating. Family decided to transition to comfort care only. Patient died at 15:21 on 12/8/2022.  Submitter does not have access to further medical information on this case. If more information is needed, please contact the admitting hospital.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: General physical health deterioration, Hypotension, Hypoxia, Intensive care, Positive airway pressure therapy
Clinical narrative: On 12/5/2022, patient presented to the emergency department from home with complaint of weakness and fatigue. He was hypoxic and required oxygen; his COVID-19 NAA test was positive. Patient was admitted to the hospital for further treatment. He was in stable condition until 12/7/2022 when his respiratory status began declining. His condition continued to decline and required more oxygen and then BiPAP. Patient became dyspneic and hypotensive and was transferred to the ICU. A family meeting was held as patient's respiratory and circulatory status was deteriorating. Family decided to transition to comfort care only. Patient died at 15:21 on 12/8/2022.  Submitter does not have access to further medical information on this case. If more information is needed, please contact the admitting hospital.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: On 12/5/2022, patient presented to the emergency department from home with complaint of weakness and fatigue. He was hypoxic and required oxygen; his COVID-19 NAA test was positive. Patient was admitted to the hospital for further treatment. He was in stable condition until 12/7/2022 when his respiratory status began declining. His condition continued to decline and required more oxygen and then BiPAP. Patient became dyspneic and hypotensive and was transferred to the ICU. A family meeting was held as patient's respiratory and circulatory status was deteriorating. Family decided to transition to comfort care only. Patient died at 15:21 on 12/8/2022.  Submitter does not have access to further medical information on this case. If more information is needed, please contact the admitting hospital.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines MOderna 12/30/20 Lot# 025J20A;  Moderna 1/27/21 Lot# 012L20A;  Moderna 11/23/21 Lot# NONE  THIS INFORMATION IS NOT IN THE STATE DATABASE;  DO NOT SEND A REQUEST FOR THIS INFORMATION
Age: 2.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event
Clinical narrative: Accidentally gave bivalent pfizer booster when the patient had completed the primary Moderna series. No symptoms or adverse events.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Vaccination error
Clinical narrative: VACCINATION ERROR NO ADVERSE REACTION  PATIENT FEELS FINE
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines Modena 2/18/21 Lot# 023M20A;  Moderna 3/18/21 Lot# 002B21A;  Moderna 11/22/21 Lot# 012H21B;  Moderna 5/1/22 Lot# 059M21A
Age: 22.0
Sex: F
Vaccine: COVID19-2
Symptoms: Exposure during pregnancy, Incorrect product formulation administered, No adverse event
Clinical narrative: Gave bivalent dose (booster) instead of 2nd dose of primary series. She did not having any adverse reaction to vaccine. She is 10w-0d and expected due date is 10/3/2023.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 4/14/21 Lot# Ew0162;  Pfizer 5/5/21 Lot# Ew0164
Age: 85.0
Sex: M
Vaccine: COVID19-2, PNC20, TDAP, VARZOS
Symptoms: Body temperature increased, Dyspnoea, Feeling abnormal, Loss of personal independence in daily activities, Wheezing
Clinical narrative: He got his vaccines 4 of them, the next day on 2/23/23 he was feeling bad, as he expected at first.  Then after that the night for 3 nights he had 101.1 temp, which his usual temp if 96.  He did not go to the hospital as he did not want the germs.  They offered him the vaccines while he was shopping, and he took them as they said it was not going to cost him anything. He took a lot of water, Nyquil at night and was having difficulty breathing.  He has sleep apnea and used that which did help him.  He started having problems with his breathing, wheezing about a week ago.  Now he has shortness of breath a lot.  If he bends down to tie his shoes he has shortness of breath, and cannot go walking due to it.  He has a nebulizer that he uses during the day, and the C-pap at night.   The shortness of breath is pretty much stable.  He does not want to breath much or take a deep breath as he has wheezing, and does not want to do that and it gets worse.    His son also has similar symptoms, but he only got the Moderna vaccine.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 4/23/21 Lot# Ew0161;  Pfizer 5/15/21 Lot# ER8736
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 3/30/21 Lot# 017B21A;  Moderna 4/27/21 Lot# 006C21A
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Dizziness, Groin pain, Nausea
Clinical narrative: -5/11/21: patient received initial dose of Moderna vaccine (PFR, COVID-19, mRNA, LNP-S, PF, 0.3mL vaccination on 05/11/2021 with lot number EW0173 at (COVID Clinic). -6/01/21: patient received 2nd dose of Moderna vaccine (PFR, COVID-19, mRNA, LNP-S, PF, 0.3mL vaccination on 06/01/2021 with lot number EW0186 at (COVID Clinic). -8/23/21: patient presented to outside clinic complaining of a bilateral rash that appeared on the hands, forearms, and ankles that reportedly appeared 2 weeks after the COVID vaccine. The patient also complained of episodic dizziness, nausea, back pain, chest pain, groin pain for the past 4 weeks. Pt reported using hydrocortisone cream on rash with minimal effect. Denies new medications, detergents/soaps/other chemicals in household.  At this visit, patient was diagnosed with "rash" and discharged home on a steroid taper and topical hydrocortisone cream. -3/3/23: patient had an appointment to establish care with a PCP. I reviewed the note from the encounter; however, there was not anything written regarding the COVID vaccine allergy. The allergy status in the chart was updated on 3/3/23 to say, "COVID-19 mRNA vaccine - rash, nausea, vomiting, GI bleed. Severity = not specified", however, i was not able to verify that GI bleed occurred. Therefore, I believe that was selected in error and the true allergy should read "rash, nausea, vomiting"
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Vomiting
Clinical narrative: -5/11/21: patient received initial dose of Moderna vaccine (PFR, COVID-19, mRNA, LNP-S, PF, 0.3mL vaccination on 05/11/2021 with lot number EW0173 at (COVID Clinic). -6/01/21: patient received 2nd dose of Moderna vaccine (PFR, COVID-19, mRNA, LNP-S, PF, 0.3mL vaccination on 06/01/2021 with lot number EW0186 at (COVID Clinic). -8/23/21: patient presented to outside clinic complaining of a bilateral rash that appeared on the hands, forearms, and ankles that reportedly appeared 2 weeks after the COVID vaccine. The patient also complained of episodic dizziness, nausea, back pain, chest pain, groin pain for the past 4 weeks. Pt reported using hydrocortisone cream on rash with minimal effect. Denies new medications, detergents/soaps/other chemicals in household.  At this visit, patient was diagnosed with "rash" and discharged home on a steroid taper and topical hydrocortisone cream. -3/3/23: patient had an appointment to establish care with a PCP. I reviewed the note from the encounter; however, there was not anything written regarding the COVID vaccine allergy. The allergy status in the chart was updated on 3/3/23 to say, "COVID-19 mRNA vaccine - rash, nausea, vomiting, GI bleed. Severity = not specified", however, i was not able to verify that GI bleed occurred. Therefore, I believe that was selected in error and the true allergy should read "rash, nausea, vomiting"
Age: 13.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Patient received less than the 0.3mL recommended dose. Specific received amount is unknown. Single dose vial was split between patient and sibling. Patient had no reaction. Parent was notified and will reschedule to receive additional booster dose per Pfizer/CDC recommendation guidelines.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Extra dose administered, Injection site pain
Clinical narrative: This dose was given in error as the patient had already received a bilvalent covid vaccine in September 2022.   As of 24 hours after the vaccine was given the patient was reporting only mild pain at the injection site and no other adverse reactions.
Age: 15.0
Sex: M
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Patient received less than the 0.3mL recommended dose. Specific received amount is unknown. Single dose vial was split between patient and sibling. Patient had no reaction. Parent was notified and will reschedule to receive additional booster dose per Pfizer/CDC recommendation guidelines.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Loss of consciousness, Syncope
Clinical narrative: Patient fainted right after receiving the shot. He became conscious about 1 minute later and stated he feels dizzy. He was then checked by healthcare team and came back to normal.
Age: 1.0
Sex: M
Vaccine: UNK, UNK, UNK, UNK
Symptoms: Pyrexia, Rash
Clinical narrative: Post 17 days from Vaccine, son exhibited 102.3° fever for 2 full days, on second day his entire body from head to foot has pink to red spots (rash) all over. He does not have any other sickness symptoms as of yet.
Age: 68.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Extra dose administered, No adverse event, Wrong patient received product
Clinical narrative: After all patients were checked in, this patient came in to be vaccinated. Staff had given RN the face sheet for a different patient. RN then gave face sheet and card to LVN. The LVN administered both Bivalent Moderna and Flu to patient. During QA, it was discovered that it was the wrong patient that was vaccinated and documented on. Patient was informed and she was okay with receiving Moderna, however she was already up do date with FLU vaccine in January 2023. Patient informed she received another FLU vaccine in the same flu season. Patient did not report any adverse reactions.
Age: 21.0
Sex: F
Vaccine: HPV9, HPV9
Symptoms: Arthralgia, Injection site erythema, Injection site swelling, Mobility decreased, Muscle tightness
Clinical narrative: Sore arm, intense shoulder pain, scratchy throat, fever, limited mobility, swelling of injection site, tensed muscle around injection site.
Age: 21.0
Sex: F
Vaccine: HPV9, HPV9
Symptoms: Pain in extremity, Pyrexia, Throat irritation
Clinical narrative: Sore arm, intense shoulder pain, scratchy throat, fever, limited mobility, swelling of injection site, tensed muscle around injection site.
Age: 21.0
Sex: F
Vaccine: HPV9, HPV9
Symptoms: Hypoaesthesia, Oropharyngeal pain, Pain in extremity
Clinical narrative: Sore arm, intense shoulder pain, scratchy throat, fever, limited mobility, swelling of injection site, tensed muscle around injection site.
Age: 21.0
Sex: F
Vaccine: HPV9, HPV9
Symptoms: Arthralgia, Injection site erythema, Injection site swelling, Mobility decreased, Muscle tightness
Clinical narrative: soreness in arm to numbness, sore throat, went to doctor 3/7/23
Age: 21.0
Sex: F
Vaccine: HPV9, HPV9
Symptoms: Pain in extremity, Pyrexia, Throat irritation
Clinical narrative: soreness in arm to numbness, sore throat, went to doctor 3/7/23
Age: 21.0
Sex: F
Vaccine: HPV9, HPV9
Symptoms: Hypoaesthesia, Oropharyngeal pain, Pain in extremity
Clinical narrative: soreness in arm to numbness, sore throat, went to doctor 3/7/23
Age: 67.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Headache, Neck pain, Oropharyngeal pain, Strawberry tongue, Streptococcus test positive
Clinical narrative: I was having a sore neck and neck pain. I thought it may have to do some dental work I had done but then it did not go away. Then I started a sore throat and I ended up going to urgent care and I was tested for Strep and it was positive. The provider said I also had "strawberry tongue" and that is how they knew it was strep. I also had a horrible headache during this. The sore throat and all that is gone but my neck still hurts.
Age: 2.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Bivalent was given before Monovalent series was started.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Urticaria
Clinical narrative: Hives
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: CSF oligoclonal band present, Central nervous system lesion, Epilepsy, Lumbar puncture abnormal, Magnetic resonance imaging head abnormal
Clinical narrative: 2-weeks after dose 1, first lifetime seizure occurred and a spinal tap confirmed oligoclonal bands in CSF. Additional generalized seizures have occurred monthly since and I received a diagnosis of epilepsy and multiple sclerosis
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging spinal abnormal, Multiple sclerosis, Seizure, Spinal cord injury
Clinical narrative: 2-weeks after dose 1, first lifetime seizure occurred and a spinal tap confirmed oligoclonal bands in CSF. Additional generalized seizures have occurred monthly since and I received a diagnosis of epilepsy and multiple sclerosis
Age: 16.0
Sex: M
Vaccine: VARCEL
Symptoms: Abdominal pain, Dysuria, Erythema, Fatigue, Nasal congestion
Clinical narrative: fever began on the night of 1/25 but did not advise staff. Reported fever again last night on 1/26. Other symptoms include fatigue, body aches, and a rash that began yesterday afternoon. Reports his last bowel movement was yesterday morning and reports he normally goes 4x/day. Denies abdominal pain, dysuria, nausea, or vomiting. Reports PMHx of Varicella but did not disclose it. EXAM: SKIN - Pink papules noted on the scalp, face near nose, neck, chest, abdomen, back, and upper extremities. Several with scabbing and with surrounding erythema. No vesicular lesions noted at this time. Approximately 30-35 papules throughout. HEENT - Erythematous nasal mucosa, swollen nasal turbinates. Tonsils 2+. No lymphadenopathy. Full ROM to neck. HEART: HR 120 by auscultation, Radial pulses 1+, cap refill < 3 sec. ABDOMEN: BS hyperactive.
Age: 16.0
Sex: M
Vaccine: VARCEL
Symptoms: Nausea, Pain, Papule, Rash, Vomiting
Clinical narrative: fever began on the night of 1/25 but did not advise staff. Reported fever again last night on 1/26. Other symptoms include fatigue, body aches, and a rash that began yesterday afternoon. Reports his last bowel movement was yesterday morning and reports he normally goes 4x/day. Denies abdominal pain, dysuria, nausea, or vomiting. Reports PMHx of Varicella but did not disclose it. EXAM: SKIN - Pink papules noted on the scalp, face near nose, neck, chest, abdomen, back, and upper extremities. Several with scabbing and with surrounding erythema. No vesicular lesions noted at this time. Approximately 30-35 papules throughout. HEENT - Erythematous nasal mucosa, swollen nasal turbinates. Tonsils 2+. No lymphadenopathy. Full ROM to neck. HEART: HR 120 by auscultation, Radial pulses 1+, cap refill < 3 sec. ABDOMEN: BS hyperactive.
Age: 15.0
Sex: M
Vaccine: VARCEL
Symptoms: Erythema, Headache, Oropharyngeal pain, Pyrexia, Rash pruritic
Clinical narrative: reported fever, headache, sore throat, and itchy bumps to body. Minor's oral temp. 102.1 F. Visible red lesions to head, neck, abdomen, wrist, and leg.
Age: 15.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: reported fever, headache, sore throat, and itchy bumps to body. Minor's oral temp. 102.1 F. Visible red lesions to head, neck, abdomen, wrist, and leg.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Erythema, Eye haemorrhage, Ocular discomfort, Ocular hyperaemia
Clinical narrative: PATIENT REPORTS HAVING SEVERE REDNESS AND "POPPING" OF BLOOD VESSELS UNDER/IN RIGHT EYE, GOING ALL THE WAY TO HER NOSE. EYES LOOKED BLOODY/BLOOD SHOT IN THE SCLERA. PRESSURE AND REDNESS HAS STARTED TO GO DOWN AS OFF TODAY 03/07/23.
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arrhythmia, Blood test, Computerised tomogram thorax normal, Dizziness, Dyspnoea
Clinical narrative: Extreme shortness of breath, fatigue, exercise intolerance, unable to work, unable to do much besides rest, dizziness, right sided numbness,
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Echocardiogram, Electrocardiogram abnormal, Exercise tolerance decreased, Fatigue, Hypoaesthesia
Clinical narrative: Extreme shortness of breath, fatigue, exercise intolerance, unable to work, unable to do much besides rest, dizziness, right sided numbness,
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypotension, Impaired work ability, Laboratory test abnormal, Loss of personal independence in daily activities, Magnetic resonance imaging head
Clinical narrative: Extreme shortness of breath, fatigue, exercise intolerance, unable to work, unable to do much besides rest, dizziness, right sided numbness,
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Nystagmus, Pulmonary function test, Scan with contrast normal
Clinical narrative: Extreme shortness of breath, fatigue, exercise intolerance, unable to work, unable to do much besides rest, dizziness, right sided numbness,
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: Paraesthesia, Rash, Rash pruritic
Clinical narrative: Patient got a prickly, itchy rash on her back that started within 24 hours of her injection and lasted about 4 or 5 days. She tried to treat with benadryl, but it didn't seem to help, but taking zyrtec did. She did not visit a doctor or go to an urgent care or ER.
Age: 78.0
Sex: F
Vaccine: COVID19-2, FLUA4
Symptoms: Cough, Electrocardiogram, Fatigue, Fibrin D dimer, Pain
Clinical narrative: First felt very tired the next day started with cough and achy feeling waited a day before taking Covid test contacted Dr., prescribed MUCINEX and over the counter cough syrup called in prescription for PAXLOVID.
Age: 78.0
Sex: F
Vaccine: COVID19-2, FLUA4
Symptoms: SARS-CoV-2 test
Clinical narrative: First felt very tired the next day started with cough and achy feeling waited a day before taking Covid test contacted Dr., prescribed MUCINEX and over the counter cough syrup called in prescription for PAXLOVID.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Chills, Decreased appetite, Migraine, Nausea
Clinical narrative: symptoms started evening of vaccination and were continuing and increasing up to 6 days after administration when patient notified this pharmacy symptoms: body aches, nausea, weakness, chills, migraine, decreased appetite
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain
Clinical narrative: symptoms started evening of vaccination and were continuing and increasing up to 6 days after administration when patient notified this pharmacy symptoms: body aches, nausea, weakness, chills, migraine, decreased appetite
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Dyspnoea, Hypersensitivity, Urticaria, Vomiting, Wheezing
Clinical narrative: severe allergic reaction occurred 5 minutes after vaccination in form of urticarial rash, wheezing, difficulty breathing, vomiting. Albuterol nebulizer started immediately, EMS called, paramedic gave epipen injection and was transferred to ER, he became stable afterwards. he has history of allergy to food and environmental allergens
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was wanting to receive 2nd dose of Moderna primary series during office visit. I went into the fridge where all vaccines are stored, and seen 1 vial of primary Moderna series with a written expiration date "2/24/2023" on the cap. After reviewing the pre- vaccination questions with patient, patient was okay to receive vaccine. I went into the vaccine preparation area, and drew up 0.50 ml of the Moderna vaccine, and administered to patient in right deltoid. After administering vaccine, and went to document vaccine in patient's record, the lot number 057A22A was not appearing in system due to expiring 1 year after manufacturing date. Patient waited the routine 15 minutes after administration of the vaccine, with no side effects or complaints, and went home.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Inflammation, Injection site pain, Pharyngeal swelling
Clinical narrative: Patient was closely monitored for 15 minutes after vaccine administration and didn't report any trouble breathing  before leaving clinic, only soreness at the injection site. Around 12:00 pm, patient returned to clinic with sensations of difficulty swallowing and swelling/inflammation in her throat. Emergency services were called immediately. Patient was given one adult epi-pen injection and vitals were taken and closely monitored. Patient was also given 25 mg IM benadryl injection per provider order. Vital signs stayed within normal limits during entire post-reaction monitoring process. After 10-15 minutes, patient was still complaining of sensation of inflammation in her throat so a second adult epi-pen injection. Vitals continued to remain stable. Ambulance team arrived shortly after second epi-pen injection and patient was taken to local hospital for care.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Decreased appetite, Fatigue, Hypersomnia, Influenza like illness
Clinical narrative: I had body aches, loss of appetite, nauseous, fatigue, sore arm, and fever of 101. I slept all day and it felt like I had the flu. I felt better the next day. Later on, I also developed deep bruising on my fingers which never been there before. I have strong black and blue points on my ankles as well.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pain in extremity, Pyrexia, Skin discolouration
Clinical narrative: I had body aches, loss of appetite, nauseous, fatigue, sore arm, and fever of 101. I slept all day and it felt like I had the flu. I felt better the next day. Later on, I also developed deep bruising on my fingers which never been there before. I have strong black and blue points on my ankles as well.
Age: 16.0
Sex: M
Vaccine: HPV9, MNQ
Symptoms: Fall, Loss of consciousness, Syncope
Clinical narrative: patient experience syncope event and briefly lost consciousness and fell but did not hit his head
Age: 67.0
Sex: M
Vaccine: UNK
Symptoms: Product dose omission issue
Clinical narrative: Pt  received a second Moderna booster after stating had never received booster.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, FLU4, MMRV
Symptoms: Injection site cellulitis, Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling
Clinical narrative: Patient's first time getting Kinrix but this is his 4th dose of Dtap as well as IPV. Patient shows having the flu vaccine in previous seasons; this being the 3rd. Per mom called clinic back 4 days later (9/30/2022) stating that her son was complaining that his leg was "itchy" on his left thigh where the vaccine was administered. Per mom stated, he has a rash and feels hot just on that area." Mom reports the rash persisted for the past 4 days, slightly less erythema and swelling. No pain reported.  Diphenhydramine 7.5ml q 6 hours for itchiness and swelling . Cephalexin 3x/day for 10 days for suspected cellulitis. Mom stated she would like to watch the rash on diphenhydramine prior to starting the cephalexin. If redness and swelling improved then no need for Cephalexin. Resolved
Age: 4.0
Sex: M
Vaccine: DTAPIPV, FLU4, MMRV
Symptoms: Injection site warmth
Clinical narrative: Patient's first time getting Kinrix but this is his 4th dose of Dtap as well as IPV. Patient shows having the flu vaccine in previous seasons; this being the 3rd. Per mom called clinic back 4 days later (9/30/2022) stating that her son was complaining that his leg was "itchy" on his left thigh where the vaccine was administered. Per mom stated, he has a rash and feels hot just on that area." Mom reports the rash persisted for the past 4 days, slightly less erythema and swelling. No pain reported.  Diphenhydramine 7.5ml q 6 hours for itchiness and swelling . Cephalexin 3x/day for 10 days for suspected cellulitis. Mom stated she would like to watch the rash on diphenhydramine prior to starting the cephalexin. If redness and swelling improved then no need for Cephalexin. Resolved
Age: 35.0
Sex: M
Vaccine: COVID19-2
Symptoms: Alanine aminotransferase normal, Anion gap, Anxiety, Aspartate aminotransferase normal, Blood albumin normal
Clinical narrative: Sudden onset of nausea, vomiting, no appetite, and insomnia 5 days after vaccination (2/16/23).  Presented to Emergency Room 2/16/23.   Symptoms worsened over the next several days, including worsening insomnia and onset of anxiety. Was prescribed scopolamine patch 1 mg and Compazine 5 mg for nausea. Lost 12+ pounds within approximately one week.  Prescribed Zolpidem 5 mg on 2/23/23 for insomnia with no relief.  Prescribed Hydroxyzine 25 mg, Lorazepam 0.5 mg on 2/24/23 with no relief for insomnia.  Prescribed Citalopram 40 mg 2/22/23 for onset of anxiety.  Vomiting subsided around 2/20/23 however, no appetite remains, early satiety remains, feel full quickly after small amounts of food
Age: 35.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood alkaline phosphatase normal, Blood bilirubin increased, Blood calcium normal, Blood chloride normal, Blood creatinine normal
Clinical narrative: Sudden onset of nausea, vomiting, no appetite, and insomnia 5 days after vaccination (2/16/23).  Presented to Emergency Room 2/16/23.   Symptoms worsened over the next several days, including worsening insomnia and onset of anxiety. Was prescribed scopolamine patch 1 mg and Compazine 5 mg for nausea. Lost 12+ pounds within approximately one week.  Prescribed Zolpidem 5 mg on 2/23/23 for insomnia with no relief.  Prescribed Hydroxyzine 25 mg, Lorazepam 0.5 mg on 2/24/23 with no relief for insomnia.  Prescribed Citalopram 40 mg 2/22/23 for onset of anxiety.  Vomiting subsided around 2/20/23 however, no appetite remains, early satiety remains, feel full quickly after small amounts of food
Age: 35.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood glucose normal, Blood magnesium normal, Blood potassium normal, Blood sodium normal, Blood urea normal
Clinical narrative: Sudden onset of nausea, vomiting, no appetite, and insomnia 5 days after vaccination (2/16/23).  Presented to Emergency Room 2/16/23.   Symptoms worsened over the next several days, including worsening insomnia and onset of anxiety. Was prescribed scopolamine patch 1 mg and Compazine 5 mg for nausea. Lost 12+ pounds within approximately one week.  Prescribed Zolpidem 5 mg on 2/23/23 for insomnia with no relief.  Prescribed Hydroxyzine 25 mg, Lorazepam 0.5 mg on 2/24/23 with no relief for insomnia.  Prescribed Citalopram 40 mg 2/22/23 for onset of anxiety.  Vomiting subsided around 2/20/23 however, no appetite remains, early satiety remains, feel full quickly after small amounts of food
Age: 35.0
Sex: M
Vaccine: COVID19-2
Symptoms: Carbon dioxide normal, Computerised tomogram normal, Decreased appetite, Early satiety, Full blood count
Clinical narrative: Sudden onset of nausea, vomiting, no appetite, and insomnia 5 days after vaccination (2/16/23).  Presented to Emergency Room 2/16/23.   Symptoms worsened over the next several days, including worsening insomnia and onset of anxiety. Was prescribed scopolamine patch 1 mg and Compazine 5 mg for nausea. Lost 12+ pounds within approximately one week.  Prescribed Zolpidem 5 mg on 2/23/23 for insomnia with no relief.  Prescribed Hydroxyzine 25 mg, Lorazepam 0.5 mg on 2/24/23 with no relief for insomnia.  Prescribed Citalopram 40 mg 2/22/23 for onset of anxiety.  Vomiting subsided around 2/20/23 however, no appetite remains, early satiety remains, feel full quickly after small amounts of food
Age: 35.0
Sex: M
Vaccine: COVID19-2
Symptoms: Gastric disorder, Gastritis, Glomerular filtration rate, Glomerular filtration rate normal, Haematocrit normal
Clinical narrative: Sudden onset of nausea, vomiting, no appetite, and insomnia 5 days after vaccination (2/16/23).  Presented to Emergency Room 2/16/23.   Symptoms worsened over the next several days, including worsening insomnia and onset of anxiety. Was prescribed scopolamine patch 1 mg and Compazine 5 mg for nausea. Lost 12+ pounds within approximately one week.  Prescribed Zolpidem 5 mg on 2/23/23 for insomnia with no relief.  Prescribed Hydroxyzine 25 mg, Lorazepam 0.5 mg on 2/24/23 with no relief for insomnia.  Prescribed Citalopram 40 mg 2/22/23 for onset of anxiety.  Vomiting subsided around 2/20/23 however, no appetite remains, early satiety remains, feel full quickly after small amounts of food
Age: 35.0
Sex: M
Vaccine: COVID19-2
Symptoms: Haemoglobin normal, Insomnia, Lipase, Liver function test, Mean cell haemoglobin concentration increased
Clinical narrative: Sudden onset of nausea, vomiting, no appetite, and insomnia 5 days after vaccination (2/16/23).  Presented to Emergency Room 2/16/23.   Symptoms worsened over the next several days, including worsening insomnia and onset of anxiety. Was prescribed scopolamine patch 1 mg and Compazine 5 mg for nausea. Lost 12+ pounds within approximately one week.  Prescribed Zolpidem 5 mg on 2/23/23 for insomnia with no relief.  Prescribed Hydroxyzine 25 mg, Lorazepam 0.5 mg on 2/24/23 with no relief for insomnia.  Prescribed Citalopram 40 mg 2/22/23 for onset of anxiety.  Vomiting subsided around 2/20/23 however, no appetite remains, early satiety remains, feel full quickly after small amounts of food
Age: 35.0
Sex: M
Vaccine: COVID19-2
Symptoms: Mean cell haemoglobin normal, Mean cell volume normal, Metabolic function test, Nausea, Oesophagitis
Clinical narrative: Sudden onset of nausea, vomiting, no appetite, and insomnia 5 days after vaccination (2/16/23).  Presented to Emergency Room 2/16/23.   Symptoms worsened over the next several days, including worsening insomnia and onset of anxiety. Was prescribed scopolamine patch 1 mg and Compazine 5 mg for nausea. Lost 12+ pounds within approximately one week.  Prescribed Zolpidem 5 mg on 2/23/23 for insomnia with no relief.  Prescribed Hydroxyzine 25 mg, Lorazepam 0.5 mg on 2/24/23 with no relief for insomnia.  Prescribed Citalopram 40 mg 2/22/23 for onset of anxiety.  Vomiting subsided around 2/20/23 however, no appetite remains, early satiety remains, feel full quickly after small amounts of food
Age: 35.0
Sex: M
Vaccine: COVID19-2
Symptoms: Oesophagogastroduodenoscopy abnormal, Protein total normal, Red blood cell count normal, Vomiting, Weight decreased
Clinical narrative: Sudden onset of nausea, vomiting, no appetite, and insomnia 5 days after vaccination (2/16/23).  Presented to Emergency Room 2/16/23.   Symptoms worsened over the next several days, including worsening insomnia and onset of anxiety. Was prescribed scopolamine patch 1 mg and Compazine 5 mg for nausea. Lost 12+ pounds within approximately one week.  Prescribed Zolpidem 5 mg on 2/23/23 for insomnia with no relief.  Prescribed Hydroxyzine 25 mg, Lorazepam 0.5 mg on 2/24/23 with no relief for insomnia.  Prescribed Citalopram 40 mg 2/22/23 for onset of anxiety.  Vomiting subsided around 2/20/23 however, no appetite remains, early satiety remains, feel full quickly after small amounts of food
Age: 35.0
Sex: M
Vaccine: COVID19-2
Symptoms: White blood cell count normal
Clinical narrative: Sudden onset of nausea, vomiting, no appetite, and insomnia 5 days after vaccination (2/16/23).  Presented to Emergency Room 2/16/23.   Symptoms worsened over the next several days, including worsening insomnia and onset of anxiety. Was prescribed scopolamine patch 1 mg and Compazine 5 mg for nausea. Lost 12+ pounds within approximately one week.  Prescribed Zolpidem 5 mg on 2/23/23 for insomnia with no relief.  Prescribed Hydroxyzine 25 mg, Lorazepam 0.5 mg on 2/24/23 with no relief for insomnia.  Prescribed Citalopram 40 mg 2/22/23 for onset of anxiety.  Vomiting subsided around 2/20/23 however, no appetite remains, early satiety remains, feel full quickly after small amounts of food
Age: 59.0
Sex: F
Vaccine: FLU4, HEP
Symptoms: Asthenia, Fall, General physical condition abnormal, Nausea, Posture abnormal
Clinical narrative: Early morning on 12/9/2022 at approximately 0645, it was reported that staff had ?crumped? to the floor. Emergency staff responded with EMS cart and emergency bag. Upon arrival staff was in care of other staff in chart room and vitals were being taken. BP at 171/98, HR at 137 and temp at 97.2.  Patient was A/O x4, appeared weak, leaning to side of chair. Patient c/o severe nausea prior to incident and receiving vaccinations on (12/8). Ambulance called to transport staff for further evaluation and treatment at hospital. Patient was transported and escorted to front of facility via wheelchair awaiting ambulance transport.